Invesco CurrencyShares Swiss Franc Trust: Form 10-Q for the period ended Apr 30, 2015
Filed with the SEC on Jun 9, 2015 and accepted by EDGAR at Jun 9, 2015, 19:16 ET.
Management's discussion and analysis
As filed, 10,363 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.
Cautionary Statement Regarding Forward-Looking Information
This report contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements can be identified by words such as “anticipate,” “expect,” “intend,” “plan,” “believe,” “seek,” “outlook” and “estimate” and other similar words. Forward-looking statements are based upon our current expectations and beliefs concerning future developments and their potential effects on us. Such forward-looking statements are not guarantees of future performance. Various factors may cause our actual results to differ materially from those expressed in our forward-looking statements. These factors include fluctuations in the price of the Swiss Franc, as the value of the Shares relates directly to the value of the Swiss Francs held by the Trust and price fluctuations could materially adversely affect an investment in the Shares. Readers are urged to review the “Risk Factors” section contained in the Trust’s most recent annual report on Form 10-K for a description of other risks and uncertainties that may affect an investment in the Shares.
Neither Guggenheim Specialized Products, LLC d/b/a Guggenheim Investments (the “Sponsor”) nor any other person assumes responsibility for the accuracy or completeness of forward-looking statements contained in this report. The forward-looking statements are made as of the date of this report, and will not be revised or updated to reflect actual results or changes in the Sponsor’s expectations or predictions.
Trust Overview
The CurrencyShares® Swiss Franc Trust (the “Trust”) is a grantor trust that was formed on June 8, 2006. The Trust issues shares (the “Shares”) in blocks of 50,000 (a “Basket”) in exchange for deposits of Swiss Francs and distributes Swiss Francs in connection with the redemption of Baskets. The Shares commenced trading on the New York Stock Exchange (“NYSE”) under the ticker symbol “FXF” on June 26, 2006. The primary listing of the Shares was transferred to NYSE Arca on October 30, 2007.
The Trust is a passive investment vehicle. The Trust does not have any officers, directors or employees. The investment objective of the Trust is for the Shares to reflect the price of the Swiss Franc plus accrued interest, if any, less the expenses of the Trust’s operations. The Trust does not engage in any activities designed to obtain profit from, or ameliorate losses caused by, changes in the price of the Swiss Franc. Investing in the Shares does not insulate the investor from certain risks, including price volatility.
Definition of Net Asset Value
The Trustee calculates, and the Sponsor publishes, the Trust’s Net Asset Value (“NAV”) each business day. To calculate the NAV, the Trustee adds to the amount of Swiss Francs in the Trust at the end of the preceding day accrued but unpaid interest, if any, Swiss Francs receivable under pending purchase orders and the value of other Trust assets, and subtracts the accrued but unpaid Sponsor’s fee, Swiss Francs payable under pending redemption orders and other Trust expenses and liabilities, if any. The NAV is expressed in U.S. Dollars (“USD”) based on the Swiss Francs/USD exchange rate as determined by The WM Company, at 4:00 PM (London time / London fixing) (the “Closing Spot Rate”) on each day that NYSE Arca is open for regular trading. If, on a particular evaluation day, the Closing Spot Rate has not been determined and announced by 6:00 PM (London time), then the most recent Closing Spot Rate is used to determine the NAV of the Trust unless the Trustee, in consultation with the Sponsor, determines that such price is inappropriate to use as the basis for the valuation.
The Trustee also determines the NAV per Share, which equals the NAV of the Trust, divided by the number of outstanding Shares. The NAV of the Trust and the NAV per Share are published by the Sponsor on each day that NYSE Arca is open for regular trading and are posted on the Trust’s website, www.currencyshares.com (http://www.currencyshares.com).
Movements in the Price of Swiss Franc
The investment objective of the Trust is for the Shares to reflect the price of the Swiss Franc plus accrued interest, less the expenses of the Trust’s operations. The Shares are intended to provide institutional and retail investors with a simple, cost-effective means of gaining investment benefits similar to those of holding Swiss Francs. Each outstanding Share represents a proportional interest in the Swiss Francs held by the Trust. The following chart provides recent trends on the price of the Swiss Franc. The chart illustrates movements in the price of the Swiss Franc in USD and is based on the Closing Spot Rate.
NAV per Share; Valuation of the Swiss Franc
The following chart illustrates the movement in the price of the Shares based on (1) NAV per Share, (2) the “bid” and “ask” midpoint offered on the NYSE Arca and (3) the Closing Spot Rate, expressed as a multiple of 100 Swiss Francs:
Liquidity
The Sponsor is not aware of any trends, demands, conditions or events that are reasonably likely to result in material changes to the Trust’s liquidity needs. The Trust’s Depository, JP Morgan Chase Bank, N.A., London Branch, maintains two deposit accounts for the Trust, a primary deposit account that may earn interest and a secondary deposit account that does not earn interest. Interest on the primary deposit account, if any, accrues daily and is paid monthly. The interest rate in effect as of April 30, 2015 was an annual nominal rate of -0.75%. The following chart provides the daily rate paid by the Depository since April 30, 2010:
In exchange for a fee, the Sponsor bears most of the expense incurred by the Trust. As a result, the only ordinary expense of the Trust during the periods covered by this report was the Sponsor’s fee. Each month the Depository deposits into the secondary deposit account accrued but unpaid interest, if any, and the Trustee withdraws Swiss Franc from the secondary deposit account to pay the accrued Sponsor’s fee for the previous month plus other Trust expenses, if any. When the interest deposited, if any, exceeds the sum of the Sponsor’s fee for the prior month plus other Trust expenses if any, then the Trustee converts the excess into USD at a prevailing market rate and distributes the USD as promptly as practicable to Shareholders on a pro-rata basis (in accordance with the number of Shares that they own). The Trust did not make any distributions during the quarter ended April 30, 2015.
Critical Accounting Estimates
The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires the Sponsor’s management to make estimates and assumptions that affect the reported amounts of the assets and liabilities and disclosures of contingent liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the period covered by this report.
In addition to the description below, please refer to Note 2 to the financial statements for further discussion of our accounting policies.
The functional currency of the Trust is the Swiss Franc in accordance with ASC 830, Foreign Currency Translation.
Results of Operations
As of October 31, 2014, the number of Swiss Francs owned by the Trust was 195,361,180, resulting in a redeemable capital share value of $202,914,251. During the six months ended April 30, 2015, 100,000 Shares were created in exchange for 9,745,063 Swiss Francs, and 400,000 Shares were redeemed in exchange for 39,024,101 Swiss Francs. In addition, 463,094 Swiss Francs were withdrawn to pay the portion of the Sponsor’s fee that exceeded the interest earned. As of April 30, 2015, the number of Swiss Francs owned by the Trust was 165,619,048, resulting in a redeemable capital Share value of $176,604,874.
A decrease in the Trust’s redeemable capital Share value from $202,914,251 at October 31, 2014 to $176,604,874 at April 30, 2015, was primarily the result of a decrease in the Shares outstanding from 2,000,000 at October 31, 2014 to 1,700,000 at April 30, 2015. The decrease in the Trust’s redeemable capital Share value was partially offset by an increase in the Closing Spot Rate from 1.0390 at October 31, 2014 to 1.0673 at April 30, 2015.
No interest income was earned during the three months ended April 30, 2014, the three months ended April 30, 2015, the six months ended April 30, 2014 and the six months ended April 30, 2015 due to an annual nominal interest rate which remained at or below 0.00% through those periods, as set forth in the chart above.
The Sponsor’s fee accrues daily at an annual nominal rate of 0.40% of the Swiss Francs in the Trust. Due primarily to a decrease in the weighted-average Swiss Francs in the Trust, the Sponsor’s fee decreased from $252,909 for the three months ended April 30, 2014 to $165,161 for the three months ended April 30, 2015, and decreased from $528,125 for the six months ended April 30, 2014 to $362,021 for the six months ended April 30, 2015. Because the annual interest rate paid by the depository fell below 0% (as set forth in the chart above), the Trust incurred interest expense. Due primarily to a decline in the interest rate (below 0%), interest expense increased from $0 for the three months ended April 30, 2014 to $216,160 for the three months ended April 30, 2015, and increased from $0 for the six months ended April 30, 2014 to $216,160 for the six months ended April 30, 2015.The only expenses of the Trust during the three months and six months ended April 30, 2014 were the Sponsor’s fee and interest expense.
The Trust’s net loss for the three months ended April 30, 2015 was $381,321, due to the Sponsor’s fee of $165,161 and interest expense of 216,160 exceeding interest income of $0. The Trust’s net loss for the six months ended April 30, 2015 was $578,181, due to the Sponsor’s fee of $362,021 and interest expense of 216,160 exceeding interest income of $0.
Cash dividends were not paid by the Trust during the three months ended April 30, 2014, the three months ended April 30, 2015 the six months ended April 30, 2014 and the six months ended April 30, 2015 as the Trust’s interest income did not exceed the Trust’s expenses during those periods.
Market risk
As filed, 293 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.
Except as described above with respect to the USD/Swiss Franc exchange rate and the nominal annual interest rate paid by the Depository on Swiss Francs held by the Trust, the Trust is not subject to market risk. The Trust does not hold securities and does not invest in derivative instruments.
Controls and procedures
As filed, 1,169 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.
The Trust maintains disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934) designed to ensure that material information relating to the Trust is recorded, processed and disclosed on a timely basis. The Trust’s disclosure controls and procedures are designed by or under the supervision of the Sponsor’s chief executive officer and chief financial officer, who exercise oversight over the Trust as the Trust has no officers. The chief executive officer and chief financial officer of the Sponsor have evaluated the effectiveness of the Trust’s disclosure controls and procedures as of April 30, 2015. Based on that evaluation, the chief executive officer and chief financial officer of the Sponsor have concluded that the disclosure controls and procedures of the Trust were effective as of the end of the period covered by this report.
There were no changes in the Trust’s internal control over financial reporting that occurred during the Trust’s last fiscal quarter that have materially affected, or are reasonably likely to materially affect, the Trust’s internal control over financial reporting.
Risk factors
As filed, 210 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.
There have been no material changes from the risk factors disclosed in the “Risk Factors” section of the Trust’s Annual Report on Form 10-K filed with the Securities and Exchange Commission on January 14, 2015.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2015-04-30. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 3 months2015-02-01 to 2015-04-30 | $0 | us-gaap:Revenues |
| Revenue | 6 months2014-11-01 to 2015-04-30 | $0 | us-gaap:Revenues |
| Interest expense | 3 months2015-02-01 to 2015-04-30 | $216.2k | us-gaap:InterestExpense |
| Interest expense | 6 months2014-11-01 to 2015-04-30 | $216.2k | us-gaap:InterestExpense |
| Net income | 3 months2015-02-01 to 2015-04-30 | −$381.3k | us-gaap:NetIncomeLoss |
| Net income | 6 months2014-11-01 to 2015-04-30 | −$578.2k | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months2015-02-01 to 2015-04-30 | −$0.23 | us-gaap:EarningsPerShareBasicAndDiluted |
| Diluted EPS | 6 months2014-11-01 to 2015-04-30 | −$0.32 | us-gaap:EarningsPerShareBasicAndDiluted |
| Operating cash flow | 6 months2014-11-01 to 2015-04-30 | −$482.5k | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Cash and equivalents | At period end2015-04-30 | $176.8m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2015-04-30 | $176.8m | us-gaap:AssetsCurrent |
| Current liabilities | At period end2015-04-30 | $168.6k | us-gaap:LiabilitiesCurrent |
| Shares outstanding | At period end2015-04-30 | 0 shares | dei:EntityCommonStockSharesOutstanding |
Source: SEC EDGAR, the filing index for accession 0001193125-15-217840. Last ingested by Listed: Oct 24, 2026, 15:11 ET. Listed shows no prices and gives no investment advice.